Tech Company Financing Transactions

SAManage Funding Round

SAManage, operating out of Cary, secured investment capital from Xenia Ventures and private investors.

Transaction Overview

Company Name
Announced On
1/22/2009
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors

Xenia Ventures (Lead Investor) (Anat Segal)

Proceeds Purpose
The funding will help SAManage support its rapid growth and accelerate the development of new value-added SaaS based services.

Company Information

Company Status
Private & Independent
Industry
Software
Mailing Address
117 Edinburgh South 100
Cary, NC 27511
USA
Email Address
Overview
SAManage is a leading provider of Next Generation, on demand, IT Asset Management services. Our IT audit and tracking services can benefit organizations of all sizes.
Profile
SAManage LinkedIn Company Profile
Social Media
SAManage Company Twitter Account
Company News
SAManage News
Facebook
SAManage on Facebook
YouTube
SAManage on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Doron Gordon
  Doron Gordon LinkedIn Profile  Doron Gordon Twitter Account  Doron Gordon News  Doron Gordon on Facebook
Chief Financial Officer
Itay Link
  Itay Link LinkedIn Profile  Itay Link Twitter Account  Itay Link News  Itay Link on Facebook
Chief Technical Officer
Michael Mazyar
  Michael Mazyar LinkedIn Profile  Michael Mazyar Twitter Account  Michael Mazyar News  Michael Mazyar on Facebook
VP - Engineering
Nir Tzur
  Nir Tzur LinkedIn Profile  Nir Tzur Twitter Account  Nir Tzur News  Nir Tzur on Facebook
VP - Marketing
Marc Stitt
  Marc Stitt LinkedIn Profile  Marc Stitt Twitter Account  Marc Stitt News  Marc Stitt on Facebook
VP - Product Management
Steve Stover
  Steve Stover LinkedIn Profile  Steve Stover Twitter Account  Steve Stover News  Steve Stover on Facebook
VP - Sales
Ryan van Biljon
  Ryan van Biljon LinkedIn Profile  Ryan van Biljon Twitter Account  Ryan van Biljon News  Ryan van Biljon on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/22/2009: Crux Biomedical venture capital transaction
Next: 1/22/2009: Axikin Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary